23 research outputs found

    Influence of B - site Disorder in La0.5Ca0.5Mn1xBxO3La_{0.5}Ca_{0.5}Mn_{1-x}B_{x}O_{3} (B = Fe, Ru, Al and Ga) Manganites

    Full text link
    We have investigated the influence of B - site doping on the crystal and magnetic structure in La0.5Ca0.5Mn1xBxO3La_{0.5}Ca_{0.5}Mn_{1-x}B_{x}O_{3} (B= Fe, Ru, Al and Ga) compounds using neutron diffraction, SANS, magnetization and resistivity techniques. The B - site doped samples are isostructural and possess an orthorhombic structure in \textit{Pnma} space group at 300K. A structural transition from orthorhombic to monoclinic is found to precede the magnetic transition to CE - type antiferromagnetic state in few of these samples. On doping with Fe, charge and orbitally ordered CE - type antiferromagnetic state is suppressed, followed by the growth in ferromagnetic insulating phase in 0.02x0.060.02\leq x\leq0.06 compounds. At higher Fe doping in x>0.06x>0.06, the ferromagnetic state is also suppressed and no evidence of long range magnetic ordering is observed. In Ru doped samples (0.01x0.05)(0.01\leq x\leq0.05), the ferromagnetic metallic state is favored at TC200KT{}_{C}\approx200K and TMI125KT_{MI}\approx125K and no significant change in TCT_{C} and TMIT_{MI} as a function of Ru doping is found. In contrast, with non magnetic Al substitution for 0.01x0.030.01\leq x\leq0.03, the charge ordered CE - type antiferromagnetic state coexists with the ferromagnetic metallic phase. With further increase in Al doping (0.05x0.07)(0.05\leq x\leq0.07), both CE - type antiferromagnetic and ferromagnetic phases are gradually suppressed. This behavior is accompanied by the evolution of A - type antiferromagnetic insulating state. Eventually, at higher Al doping (0.10x0.13)(0.10\leq x\leq0.13), this phase is also suppressed and signature of spin glass like transition are evident in M(T). Likewise, substitution with Ga is observed to induce similar effects as described for Al doped samples. The presence of short ranged ferromagnetic ordering has been further explored using SANS measurements in few of the selected samples.Comment: To appear in Journal of Physics: Condensed Matte

    Household, community, sub-national and country-level predictors of primary cooking fuel switching in nine countries from the PURE study

    Get PDF
    Introduction. Switchingfrom polluting (e.g. wood, crop waste, coal)to clean (e.g. gas, electricity) cooking fuels can reduce household air pollution exposures and climate-forcing emissions.While studies have evaluated specific interventions and assessed fuel-switching in repeated cross-sectional surveys, the role of different multilevel factors in household fuel switching, outside of interventions and across diverse community settings, is not well understood. Methods.We examined longitudinal survey data from 24 172 households in 177 rural communities across nine countries within the Prospective Urban and Rural Epidemiology study.We assessed household-level primary cooking fuel switching during a median of 10 years offollow up (∼2005–2015).We used hierarchical logistic regression models to examine the relative importance of household, community, sub-national and national-level factors contributing to primary fuel switching. Results. One-half of study households(12 369)reported changing their primary cookingfuels between baseline andfollow up surveys. Of these, 61% (7582) switchedfrom polluting (wood, dung, agricultural waste, charcoal, coal, kerosene)to clean (gas, electricity)fuels, 26% (3109)switched between different polluting fuels, 10% (1164)switched from clean to polluting fuels and 3% (522)switched between different clean fuels

    Household, community, sub-national and country-level predictors of primary cooking fuel switching in nine countries from the PURE study

    Get PDF

    Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    Get PDF
    BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed
    corecore